LJPC Insider Trading Activity and SEC Form 4 Filings
LJPC insider trading summary
No open-market insider purchases or sales of La Jolla Pharmaceutical Co (LJPC) have been reported on SEC Form 4 in the past 12 months.
Latest LJPC insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Dec 6, 2021 | David A Ramsay | Director | Buy | $3K (785 @ $3.77) |
| Dec 6, 2021 | David A Ramsay | Director | Buy | $4K (1,000 @ $3.84) |
| Dec 6, 2021 | David A Ramsay | Director | Buy | $12K (3,000 @ $3.87) |
| Dec 6, 2021 | David A Ramsay | Director | Buy | $4K (1,000 @ $3.80) |
| Dec 6, 2021 | David A Ramsay | Director | Buy | $4K (1,000 @ $3.75) |
| Dec 6, 2021 | David A Ramsay | Director | Buy | $8K (2,215 @ $3.82) |
| Dec 6, 2021 | David A Ramsay | Director | Buy | $4K (1,000 @ $3.81) |
| Dec 3, 2021 | David A Ramsay | Director | Buy | $7K (2,000 @ $3.63) |
| Dec 3, 2021 | David A Ramsay | Director | Buy | $4K (1,000 @ $3.68) |
| Dec 3, 2021 | David A Ramsay | Director | Buy | $1K (399 @ $3.64) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.